Diego Raffo
Overview
Explore the profile of Diego Raffo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raffo D, Maglioco A, Fernandez Sasso D
Mol Biol Rep
. 2021 Feb;
48(2):2005.
PMID: 33606152
No abstract available.
2.
Raffo D, Maglioco A, Fernandez Sasso D
Mol Biol Rep
. 2021 Jan;
48(2):1559-1565.
PMID: 33398679
Mesenchymal stem cells (MSC) differentiate into different cell types and have immunomodulatory and paracrine effects. Cryopreservation of umbilical cord tissue as a source of MSC is very promising for regenerative...
3.
Raffo D, Perez Tito L, Pes M, Fernandez Sasso D
Vox Sang
. 2019 Feb;
114(3):283-289.
PMID: 30734294
Background And Objectives: Umbilical cord blood is considered an alternative source of hematopoietic stem cells. Standard banking procedures use 50/55% DMSO in dextran 40 for cryopreservation and dextran-based solutions for...
4.
Berardi D, Raffo D, Todaro L, Simian M
Cancer Res Treat
. 2017 Jan;
49(4):869-879.
PMID: 28052658
Purpose: We investigated the effects of laminin on the fraction of cells with self-renewing capacity in the estrogen-dependent, tamoxifen-sensitive LM05-E breast cancer cell line. We also determined whether laminin affected...
5.
Raffo D, Pontiggia O, Bal De Kier Joffe E, Simian M
Oncol Rep
. 2014 Oct;
33(1):439-47.
PMID: 25338647
Estrogens and tamoxifen do not only exert their effects at the genomic level, but also play a role at the cell membrane activating downstream signaling pathways. We recently characterized an...
6.
Raffo D, Berardi D, Pontiggia O, Todaro L, Bal De Kier Joffe E, Simian M
Breast Cancer Res Treat
. 2013 Nov;
142(3):537-48.
PMID: 24258256
Using the M05 mouse mammary tumor model and the MCF-7 cell line, we investigated the effect of tamoxifen treatment on the fraction of breast cancer cells with self-renewing capacity both...
7.
Nahmod K, Walther T, Cambados N, Fernandez N, Meiss R, Tappenbeck N, et al.
FASEB J
. 2012 Jan;
26(5):1982-94.
PMID: 22286690
Angiotensin II (AngII), the main effector peptide of the renin-angiotensin system (RAS), participates in multiple biological processes, including cell growth, apoptosis, and tissue remodeling. Since AngII activates, in different cell...
8.
Pontiggia O, Sampayo R, Raffo D, Motter A, Xu R, Bissell M, et al.
Breast Cancer Res Treat
. 2011 Sep;
133(2):459-71.
PMID: 21935603
Tamoxifen resistance has been largely attributed to genetic alterations in the epithelial tumor cells themselves, such as overexpression of HER-2/Neu. However, in the clinic, only about 15-20% of cases of...
9.
Pontiggia O, Rodriguez V, Fabris V, Raffo D, Bumaschny V, Fiszman G, et al.
Breast Cancer Res Treat
. 2008 Jul;
116(2):247-55.
PMID: 18622696
Currently, to our knowledge, there are no continuous cell lines derived from estrogen dependent, tamoxifen sensitive spontaneous mouse mammary carcinomas. We describe here the establishment and characterization of a cell...